4//SEC Filing
Madan Ajay 4
Accession 0001209191-22-015131
CIK 0001658247other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 9:00 PM ET
Size
9.1 KB
Accession
0001209191-22-015131
Insider Transaction Report
Form 4
Madan Ajay
Chief Development Officer
Transactions
- Sale
Common Stock
2022-03-01$19.88/sh+9,000$178,920→ 176,995 total - Award
Common Stock (right to buy)
2022-02-28+65,400→ 65,400 totalExercise: $20.02Exp: 2032-02-27→ Common Stock (65,400 underlying) - Award
Common Stock
2022-02-28+13,950→ 185,995 total
Footnotes (3)
- [F1]The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 25% vesting annually beginning on March 15, 2023.
- [F2]The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date.
- [F3]The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of February 28, 2022.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
Related Parties
1- filerCIK 0001807856
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 9:00 PM ET
- Size
- 9.1 KB